Gravatom has experienced a surge in interest in its PET (Positron Emission Tomography) engineering solutions developed for the nuclear
medicine industry. PET is a vital nuclear imaging technique for the earlier detection of cancers, brain and cardiovascular disorders. Over the past
four years, Gravatom has been applying its extensive knowledge of engineering for GMP production of radiopharmaceuticals towards the
development of systems for the production of PET tracer. For more information please contact Gravatom on 01489 897300, email sales@gravatom.com or visit www.gravatom.com
For more information on this company click here
To add your company click here
JLR teams with Allye Energy on portable battery storage
This illustrates the lengths required to operate electric vehicles in some circumstances. It is just as well few electric Range Rovers will go off...